Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature.

Galanopoulos M, Tsoukalas N, Papanikolaou IS, Tolia M, Gazouli M, Mantzaris GJ.

World J Gastrointest Oncol. 2017 Apr 15;9(4):142-152. doi: 10.4251/wjgo.v9.i4.142. Review.

2.

DNA methylation assay for colorectal carcinoma.

Chen JJ, Wang AQ, Chen QQ.

Cancer Biol Med. 2017 Feb;14(1):42-49. doi: 10.20892/j.issn.2095-3941.2016.0082.

3.

Proposed score for the self-assessment of an endoscopy department performance in colonoscopy screening.

Sporea I, Popescu A, Sirli R, Pascu O, Prelipcean CC, Dobru D, Bota S, Gherhardt D, Gradinaru O, Popescu M.

Clujul Med. 2017;90(1):28-32. doi: 10.15386/cjmed-730. Epub 2017 Jan 15.

4.

A Review of Colorectal Cancer Detection Modalities, Stool DNA, and Fecal Immunochemistry Testing in Adults Over the Age of 50.

Janz T, Lu K, Povlow MR, Urso B.

Cureus. 2016 Dec 16;8(12):e931. doi: 10.7759/cureus.931. Review.

5.
6.

Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.

Uratani R, Toiyama Y, Kitajima T, Kawamura M, Hiro J, Kobayashi M, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Goel A, Kusunoki M.

PLoS One. 2016 Oct 19;11(10):e0160722. doi: 10.1371/journal.pone.0160722. eCollection 2016.

7.

Use of Biomarkers in Screening for Cancer.

Duffy MJ.

EJIFCC. 2010 Mar 25;21(1):1-12. eCollection 2010 Mar.

8.

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary.

Tinmouth J, Vella ET, Baxter NN, Dubé C, Gould M, Hey A, Ismaila N, McCurdy BR, Paszat L.

Can J Gastroenterol Hepatol. 2016;2016:2878149. doi: 10.1155/2016/2878149. Epub 2016 Aug 14. Review.

9.

Colorectal cancer development and advances in screening.

Simon K.

Clin Interv Aging. 2016 Jul 19;11:967-76. doi: 10.2147/CIA.S109285. eCollection 2016. Review.

10.

Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.

Bastaminejad S, Taherikalani M, Ghanbari R, Akbari A, Shabab N, Saidijam M.

Iran Biomed J. 2017 Mar;21(2):106-113. Epub 2016 Jul 19.

11.
12.

Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.

Li B, Gan A, Chen X, Wang X, He W, Zhang X, Huang R, Zhou S, Song X, Xu A.

PLoS One. 2016 May 9;11(5):e0155095. doi: 10.1371/journal.pone.0155095. eCollection 2016.

13.

The levels of serine proteases in colon tissue interstitial fluid and serum serve as an indicator of colorectal cancer progression.

Xie Y, Chen L, Lv X, Hou G, Wang Y, Jiang C, Zhu H, Xu N, Wu L, Lou X, Liu S.

Oncotarget. 2016 May 31;7(22):32592-606. doi: 10.18632/oncotarget.8693.

14.

Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.

Bailey JR, Aggarwal A, Imperiale TF.

Gut Liver. 2016 Mar;10(2):204-11. doi: 10.5009/gnl15420. Review.

15.

Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer.

Salehi R, Atapour N, Vatandoust N, Farahani N, Ahangari F, Salehi AR.

Adv Biomed Res. 2015 Nov 30;4:252. doi: 10.4103/2277-9175.170677. eCollection 2015.

16.

Exosomal microRNA Biomarkers: Emerging Frontiers in Colorectal and Other Human Cancers.

Tovar-Camargo OA, Toden S, Goel A.

Expert Rev Mol Diagn. 2016;16(5):553-67. doi: 10.1586/14737159.2016.1156535. Epub 2016 Mar 16. Review.

17.

The Diagnostic Performance of Stool DNA Testing for Colorectal Cancer: A Systematic Review and Meta-Analysis.

Zhai RL, Xu F, Zhang P, Zhang WL, Wang H, Wang JL, Cai KL, Long YP, Lu XM, Tao KX, Wang GB.

Medicine (Baltimore). 2016 Feb;95(5):e2129. doi: 10.1097/MD.0000000000002129. Review.

18.

Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test results.

Wakamura K, Kudo SE, Miyachi H, Kodama K, Hayashi S, Maeda Y, Ogawa Y, Kouyama Y, Kataoka SI, Kato K, Ichimasa K, Misawa M, Mori Y, Kudo T, Hayashi T, Ishida F, Ohkoshi S.

Mol Clin Oncol. 2015 Sep;3(5):1019-1024. Epub 2015 Jul 1.

19.

Developments in Screening Tests and Strategies for Colorectal Cancer.

Sovich JL, Sartor Z, Misra S.

Biomed Res Int. 2015;2015:326728. doi: 10.1155/2015/326728. Epub 2015 Oct 4. Review.

20.

Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives.

Dhaliwal A, Vlachostergios PJ, Oikonomou KG, Moshenyat Y.

World J Gastrointest Oncol. 2015 Oct 15;7(10):178-83. doi: 10.4251/wjgo.v7.i10.178. Review.

Supplemental Content

Support Center